UBS O'Connor’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

UBS O'Connor’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$510K	Sell
2023 Q1	$477K	Buy
2019 Q1	–	Sell
2018 Q4	$964K	Buy
2018 Q3	$1.01M	Buy
2017 Q4	–	Sell
2017 Q3	$2.59M	Buy